Paid by 14:30 Mon–Fri → dispatched today · Free UK tracked delivery on £150+

For laboratory research use only. Not for human or veterinary use. Not a medicine, food supplement or cosmetic.

Your basket

Your basket is empty.

Browse peptides
GH Secretagogues & GHRH Analogues

CJC-1295 with DAC

Also known as CJC-1295 DAC

Choose size

Price includes UK VAT · SKU CJC-WITH-DAC-2mg

  • Paid by 14:30 Mon–Fri: dispatched the same day
  • Free Royal Mail Tracked 24 on UK orders of £150 or more
  • Plain, discreet packaging

Research use only. Not for human or veterinary use. Not a medicine, food supplement or cosmetic.

WADA notice. This compound is on the World Anti-Doping Agency Prohibited List. It is supplied for laboratory research and must not be used in sport.

Current batch

Batch certificates are moving here from the old Quality Centre. To get the CoA for the batch you would receive today, email [email protected] with the SKU.

Overview

CJC-1295 with DAC – 2 mg

CJC-1295 with DAC (Drug Affinity Complex) is a synthetic analog of growth hormone-releasing hormone (GHRH), engineered for extended half-life through albumin binding. It’s designed to stimulate prolonged release of endogenous growth hormone (GH) and insulin-like growth factor 1 (IGF-1), with a markedly longer half-life than unmodified GHRH analogues. Supplied as a lyophilised powder for research use only, it serves as a powerful tool in studies of hormone axis regulation, tissue metabolism, and recovery pathways.

Research Focus and Areas of Interest

1. Prolonged GH-IGF-1 Release

CJC-1295 with DAC maintains elevated GH and IGF-1 levels for multiple days post-administration, supporting investigations into sustained anabolic signaling and endocrine feedback regulation.

2. GHRH Receptor Activation

As a modified GHRH analog, it binds the GHRH receptor in the anterior pituitary to drive GH secretion in a controlled, sustained manner—ideal for research into hormonal cascade dynamics.

3. Metabolic and Tissue Applications

Researchers explore its utility in examining changes in lean mass, fat metabolism, and tissue remodeling through GH/IGF-1 mediated pathways.

4. Comparative Pharmacokinetics

CJC-1295 with DAC contrasts sharply with the non-DAC form in half-life—an important variable in experimental design considering temporal hormone dynamics and receptor feedback.

Conclusion

CJC-1295 with DAC is a robust research peptide for modeling prolonged endogenous GH/IGF-1 axis activation. It offers a controlled system for studying anabolic pathways, endocrine signaling, and metabolic regulation. Supplied strictly for research use only, it is not intended for human or veterinary application.


Technical Information:

• Synonyms: CJC-1295 DAC; DAC:GRF (Drug Affinity Complex–GHRH analog)

• Modified Single-Letter Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys-DAC

• IUPAC Condensed Amino Acid Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys-DAC

• Molecular Weight: ~3648 g/mol

• CAS Number: 446262-90-4

• PubChem CID: 56841945

• Further Reference: PubChem Link


Stability, Source, and Handling

• Stability: Stable up to 36 months when stored at –20 °C or colder, protected from light and moisture.

• Source: Synthesized using solid-phase peptide methods and supplied with Certificate of Analysis (COA) confirming purity and identity.

• Reconstitution: Dissolve in sterile water or PBS under aseptic conditions; aliquot and store at –80 °C following reconstitution to minimize degradation.

• Usage: Product is prepared for LABORATORY RESEARCH ONLY. Intended for controlled in-vitro and in-vivo laboratory protocols.

Reconstitution supplies